New vaccine booster aims to shield against multiple coronaviruses
NCT ID NCT07113106
First seen Apr 15, 2026 · Last updated Jun 14, 2026 · Updated 7 times
Summary
This early-stage trial tests a new booster vaccine, CD40.Pan.CoV, designed to protect against several types of coronaviruses. About 48 healthy adults in France will receive either a low or high dose, with or without an adjuvant (a substance that boosts immune response). The main goals are to check the vaccine's safety and measure the antibodies it produces.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIC 1403 CHU de Lille
Lille, 59037, France
-
CIC 1405 CHU Clermont Ferrand
Clermont-Ferrand, 63000, France
-
CIC 1413 CHU de Nantes
Nantes, 44093, France
-
CIC 1417 Cochin-Pasteur Hôpital Cochin
Paris, 75014, France
-
CIC 1427 Hôpital St Louis
Paris, 75475, France
-
Centre de Recherche Clinique CHU de Caen Normandie
Caen, 14033, France
-
Hôpital Henri Mondor
Créteil, 94010, France
Conditions
Explore the condition pages connected to this study.